94 related articles for article (PubMed ID: 15618965)
1. Role of B-cell antigen receptor-associated molecules and lipid rafts in CD5-induced apoptosis of B CLL cells.
Renaudineau Y; Nédellec S; Berthou C; Lydyard PM; Youinou P; Pers JO
Leukemia; 2005 Feb; 19(2):223-9. PubMed ID: 15618965
[TBL] [Abstract][Full Text] [Related]
2. CD5-induced apoptosis of B cells in some patients with chronic lymphocytic leukemia.
Pers JO; Berthou C; Porakishvili N; Burdjanadze M; Le Calvez G; Abgrall JF; Lydyard PM; Youinou P; Jamin C
Leukemia; 2002 Jan; 16(1):44-52. PubMed ID: 11840262
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneous intracellular expression of B-cell receptor components in B-cell chronic lymphocytic leukaemia (B-CLL) cells and effects of CD79b gene transfer on surface immunoglobulin levels in a B-CLL-derived cell line.
Minuzzo S; Indraccolo S; Tosello V; Piovan E; Cabrelle A; Trentin L; Semenzato G; Amadori A
Br J Haematol; 2005 Sep; 130(6):878-89. PubMed ID: 16156858
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis induction by hypercross-linking of the surface antigen CD5 with anti-CD5 monoclonal antibodies in B cell chronic lymphocytic leukemia.
Cioca DP; Kitano K
Leukemia; 2002 Mar; 16(3):335-43. PubMed ID: 11896536
[TBL] [Abstract][Full Text] [Related]
5. B-cell receptor translocation to lipid rafts and associated signaling differ between prognostically important subgroups of chronic lymphocytic leukemia.
Allsup DJ; Kamiguti AS; Lin K; Sherrington PD; Matrai Z; Slupsky JR; Cawley JC; Zuzel M
Cancer Res; 2005 Aug; 65(16):7328-37. PubMed ID: 16103084
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the mRNA expression profile of B-cell receptor components in normal CD5-high B-lymphocytes and chronic lymphocytic leukemia: a key role of ZAP70.
Gladkikh AA; Potashnikova DM; Tatarskiy V; Yastrebova M; Khamidullina A; Barteneva N; Vorobjev I
Cancer Med; 2017 Dec; 6(12):2984-2997. PubMed ID: 29125235
[TBL] [Abstract][Full Text] [Related]
7. Quantitative analysis of CD79b, CD5 and CD19 in mature B-cell lymphoproliferative disorders.
Cabezudo E; Carrara P; Morilla R; Matutes E
Haematologica; 1999 May; 84(5):413-8. PubMed ID: 10329919
[TBL] [Abstract][Full Text] [Related]
8. CD5 provides viability signals to B cells from a subset of B-CLL patients by a mechanism that involves PKC.
Perez-Chacon G; Vargas JA; Jorda J; Morado M; Rosado S; Martin-Donaire T; Losada-Fernandez I; Rebolleda N; Perez-Aciego P
Leuk Res; 2007 Feb; 31(2):183-93. PubMed ID: 16725198
[TBL] [Abstract][Full Text] [Related]
9. Aberrant B cell receptor signaling from B29 (Igbeta, CD79b) gene mutations of chronic lymphocytic leukemia B cells.
Gordon MS; Kato RM; Lansigan F; Thompson AA; Wall R; Rawlings DJ
Proc Natl Acad Sci U S A; 2000 May; 97(10):5504-9. PubMed ID: 10792036
[TBL] [Abstract][Full Text] [Related]
10. Leukemia-associated changes identified by quantitative flow cytometry. II. CD5 over-expression and monitoring in B-CLL.
Lavabre-Bertrand T; Janossy G; Exbrayat C; Bourquard P; Duperray C; Navarro M
Leukemia; 1994 Sep; 8(9):1557-63. PubMed ID: 7522294
[TBL] [Abstract][Full Text] [Related]
11. Lyn-mediated SHP-1 recruitment to CD5 contributes to resistance to apoptosis of B-cell chronic lymphocytic leukemia cells.
Tibaldi E; Brunati AM; Zonta F; Frezzato F; Gattazzo C; Zambello R; Gringeri E; Semenzato G; Pagano MA; Trentin L
Leukemia; 2011 Nov; 25(11):1768-81. PubMed ID: 21701493
[TBL] [Abstract][Full Text] [Related]
12. B cell response to surface IgM cross-linking identifies different prognostic groups of B-chronic lymphocytic leukemia patients.
Nédellec S; Renaudineau Y; Bordron A; Berthou C; Porakishvili N; Lydyard PM; Pers JO; Youinou P
J Immunol; 2005 Mar; 174(6):3749-56. PubMed ID: 15749915
[TBL] [Abstract][Full Text] [Related]
13. An alternatively spliced form of CD79b gene may account for altered B-cell receptor expression in B-chronic lymphocytic leukemia.
Alfarano A; Indraccolo S; Circosta P; Minuzzo S; Vallario A; Zamarchi R; Fregonese A; Calderazzo F; Faldella A; Aragno M; Camaschella C; Amadori A; Caligaris-Cappio F
Blood; 1999 Apr; 93(7):2327-35. PubMed ID: 10090943
[TBL] [Abstract][Full Text] [Related]
14. From normal to clonal B cells: Chronic lymphocytic leukemia (CLL) at the crossroad between neoplasia and autoimmunity.
Ghia P; Scielzo C; Frenquelli M; Muzio M; Caligaris-Cappio F
Autoimmun Rev; 2007 Dec; 7(2):127-31. PubMed ID: 18035322
[TBL] [Abstract][Full Text] [Related]
15. Asymmetrical phosphorylation and function of immunoreceptor tyrosine-based activation motif tyrosines in B cell antigen receptor signal transduction.
Pao LI; Famiglietti SJ; Cambier JC
J Immunol; 1998 Apr; 160(7):3305-14. PubMed ID: 9531288
[TBL] [Abstract][Full Text] [Related]
16. CD5-positive B cells at the crossroads of B cell malignancy and nonorgan-specific autoimmunity.
Youinou P; Pers JO; Jamin C; Lydyard PM
Pathol Biol (Paris); 2000 Jul; 48(6):574-6. PubMed ID: 10965537
[TBL] [Abstract][Full Text] [Related]
17. Antigen receptor nonresponsiveness in chronic lymphocytic leukemia B cells.
Lankester AC; van Schijndel GM; van der Schoot CE; van Oers MH; van Noesel CJ; van Lier RA
Blood; 1995 Aug; 86(3):1090-7. PubMed ID: 7620163
[TBL] [Abstract][Full Text] [Related]
18. CD79a detected by ZL7.4 separates chronic lymphocytic leukemia from mantle cell lymphoma in the leukemic phase.
Bell PB; Rooney N; Bosanquet AG
Cytometry; 1999 Jun; 38(3):102-5. PubMed ID: 10397328
[TBL] [Abstract][Full Text] [Related]
19. Variable expression of CD49d antigen in B cell chronic lymphocytic leukemia is related to disease stages.
Eksioğlu-Demiralp E; Alpdoğan O; Aktan M; Firatli T; Oztürk A; Budak T; Bayik M; Akoğlu T
Leukemia; 1996 Aug; 10(8):1331-9. PubMed ID: 8709639
[TBL] [Abstract][Full Text] [Related]
20. CD5 is dissociated from the B-cell receptor in B cells from bovine leukemia virus-infected, persistently lymphocytotic cattle: consequences to B-cell receptor-mediated apoptosis.
Cantor GH; Pritchard SM; Dequiedt F; Willems L; Kettmann R; Davis WC
J Virol; 2001 Feb; 75(4):1689-96. PubMed ID: 11160667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]